Vanadate Amplifies Receptor-Mediated Accumulation Of Inositol Trisphosphates And Inhibits Inositol Tris- And Tetrakis-Phosphatase Activities

Department

neurobiology

Document Type

Article

Abstract

Lithium ion, which inhibits hydrolytic degradation of inositol monophosphates, is the most common therapeutic agent used in the control of bipolar disorder. There exists evidence that elevated elemental vanadium levels may play an etiological role in at least some forms of manic-depression. Here we demonstrate that vanadate treatment of intact cells from several different clonal lines synergistically induces substantial augmentation in neurotransmitter receptor-mediated or growth factor receptor-triggered inositol trisphosphate accumulation in situ. Furthermore, studies done using cellular extracts indicate that effects of vanadate treatment in situ may be due to its ability to inhibit hydrolysis of inositol 1,4,5-trisphosphate, inositol 1,3,4-trisphosphate, and inositol 1,3,4,5-tetrakisphosphate in vitro. These results suggest that vanadate treatment may facilitate characterization of inositol phosphate metabolism and intracellular signaling. © 1992.

Publication Date

1-6-1992

Publication Title

Neuroscience Letters

ISSN

03043940

Volume

134

Issue

2

First Page

157

Last Page

160

Digital Object Identifier (DOI)

10.1016/0304-3940(92)90505-2

This document is currently not available here.

Share

COinS